Form 4 for KALA KALA BIO, Inc.
Accepted 2023-06-23 00:00:00 ET · period of report 2023-06-22 · accession 0001415889-23-010290 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-23 | 2023-06-22 | KALA | PERRY GREGORY D | Dir | A - Grant | $0.00 | +6,956 | 9,494 | +274% | $0 |
| DM | 2023-06-23 | 2023-06-22 | KALA | PERRY GREGORY D | Dir | A - Grant | $0.00 | +10.3K | 2,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-22 | A | A | 5,856 | $0.00 | 8,394 | D | — | — | (F1) Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 1/3 of the shares underlying the RSUs on June 22, 2024, as to 1/3 of the shares underlying the RSUs on June 22, 2025 and as to the final 1/3 of shares underlying the RSUs on June 22, 2026. (F2) Includes 8,394 unvested RSUs. |
| 2 | Common | Common Stock | 2023-06-22 | A | A | 1,100 | $0.00 | 9,494 | D | — | — | (F3) Grant of RSUs under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 22, 2024 or (ii) the date of the first annual meeting following June 22, 2023. (F4) Includes 9,494 unvested RSUs. |
| 3 | Derivative | Stock Option (right to buy) | 2023-06-22 | A | A | 7,808 | $0.00 | 7,808 | D | $14.56 · — to 2033-06-21 | 7,808 Common Stock | (F5) This option was granted on June 22, 2023 and vests over four years beginning on the vesting commencement date of June 22, 2023, with 25% of the shares underlying the option vesting on June 22, 2024, and an additional 1/48th the shares underlying the option vesting at the end of each successive one-month period thereafter. |
| 4 | Derivative | Stock Option (right to buy) | 2023-06-22 | A | A | 2,500 | $0.00 | 2,500 | D | $14.56 · — to 2033-06-21 | 2,500 Common Stock | (F6) This option was granted on June 22, 2023 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 22, 2024 or (ii) the date of the first annual meeting following June 22, 2023. |